Skip to content

Remote Self-training Program for Patients With Postural Orthostatic Tachycardia Syndrome

Remote Self-training Program for Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04603157
Enrollment
60
Registered
2020-10-26
Start date
2020-01-01
Completion date
2022-02-18
Last updated
2022-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postural Orthostatic Tachycardia Syndrome

Brief summary

The purpose of this research is to evaluate if a hybrid semi-supervised remote exercise training program can reduce symptoms and improve quality of life and physical fitness in individuals with postural orthostatic tachycardia syndrome (POTS) and determine if this program is more effective than current standard of care.

Detailed description

To answer these questions, 60 individuals with POTS will be recruited to complete a symptom-limited cardiopulmonary exercise test with measures of cardiac output, autonomic function testing, blood volume measurement, and QOL questionnaires at baseline and following 3-months of treatment. Thirty participants will be randomized to continue with the standard of care which can include lower body and core strengthening, fluids, salt, medications and sometimes exercise. The other thirty participants will be asked to complete at least three exercise training sessions a week (progressing to 3hrs/wk of aerobic and 1hr/wk of strength training) and receive eight supervised training sessions over the 3-month treatment period. All participants will be provided with a polar heart rate monitor which will be linked to a connected health application to allow patients to track any aerobic workout, ensure during a session they are in the correct training zone, and allow the study team to remotely monitor adherence.

Interventions

BEHAVIORALHybrid Exercise Training

Personalized exercise program completing at least 3 aerobic exercise sessions a week and receive eight supervised training sessions over the 3-months

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be 18 years old or older * Meet diagnosis criteria for POTS = a heart rate increase of ≥ 30bpm with supine to 10 minutes of standing or head-up tilt or heart rate exceeding 120 ppm after 10 minutes of standing or tilt without evidence of orthostatic hypertension (a fall in BP of \> 20/10 mmHg) * Been diagnosed with POTS ≥6 months prior to participation in the study (chronic) * Female subjects must not be pregnant or trying to become pregnant during duration of study participation * Those in exercise training group must be on stable medications for at least 1 month and medication must remain consistent for duration of study participation. For those in the standard of care group, a change in medication will be allowed within the first month following baseline testing, but then must remain consistent until 3-month testing time point. * Ehlers-Danlos Syndrome (EDS) patients will be included, but will target equal randomization between treatment groups

Exclusion criteria

* Individual is not eligible if they are currently exercising, cut off \>30 minutes of structured exercise/physical activity per week. (assessed by Global Physical Activity Questionnaire)

Design outcomes

Primary

MeasureTime frameDescription
Change Peak Oxygen consumption at 3 monthsbaseline and following 3 month interventionpeak oxygen consumption measured from maximal cardiopulmonary exercise testing

Secondary

MeasureTime frameDescription
Change in Composite Autonomic Symptom Score (COMPASS 31) at 3 monthsbaseline and following 3 month interventionComposite Autonomic Symptom Score a questionnaire of autonomic symptoms severity in 6 domains. Total score ranges from 0-100. Higher score means more severe autonomic symptoms.
Change in Functional Ability Score at 3 monthsbaseline and following 3 month interventionFunctional Ability Score asking patient to report their degree of limitation from 0-100% in 10% increments. 100% would be no limitation, feel normal, 10% is completely bedridden.
Change in 36-Item Short Form Health Survey questionnaire (SF-36) at 3 monthsbaseline and following 3 month intervention36-Item Short Form Health Survey questionnaire to evaluate quality of life and degree of health specifically focusing on the reported physical and mental components. Scores range from 0-100, where a higher score indicated better health.
Change in heart rate with 10-min Stand test at 3 monthsbaseline and following 3 month interventionChange in heart rate in response to standing from supine to standing for 10 minutes
Change in blood volume at 3 monthsbaseline and following 3 month interventionchange in blood volume

Other

MeasureTime frameDescription
Change in matched workload rating of perceived exertion (RPE) at 3 monthsbaseline and following 3 month interventionChange in RPE at matched workload measured from maximal cardiopulmonary exercise testing
Change in anaerobic threshold oxygen consumption at 3 monthsbaseline and following 3 month interventionChange in oxygen consumption at anaerobic threshold measured from maximal cardiopulmonary exercise testing
Change in matched workload cardiac output at 3 monthsbaseline and following 3 month interventionChange in cardiac output at matched workload measured from maximal cardiopulmonary exercise testing
Change in anaerobic threshold cardiac output at 3 monthsbaseline and following 3 month interventionchange in cardiac output at anaerobic threshold measured from maximal cardiopulmonary exercise testing
Change in matched workload oxygen consumption at 3 monthsbaseline and following 3 month interventionChange in oxygen consumption at matched workload measured from maximal cardiopulmonary exercise testing
Change in anaerobic threshold heart rate at 3 monthsbaseline and following 3 month interventionChange in heart rate at anaerobic threshold measured from maximal cardiopulmonary exercise testing
Change in matched workload heart rate at 3 monthsbaseline and following 3 month interventionChange in heart rate at matched workload measured from maximal cardiopulmonary exercise testing
Change in anaerobic threshold workload at 3 monthsbaseline and following 3 month interventionchange in workload at anaerobic threshold measured from maximal cardiopulmonary exercise testing
Change in anaerobic threshold rating of perceived exertion (RPE) at 3 monthsbaseline and following 3 month interventionchange in RPE at anaerobic threshold measured from maximal cardiopulmonary exercise testing

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026